Yield10 Bioscience (YTEN.Q) Proxy Filing summary

Executive summary

• Special Meeting scheduled for November 8, 2024, to vote on four key proposals, including the sale of substantially all assets, liquidation and dissolution, adjournment authority, and a reduction in authorized shares.

• Asset Sale involves selling nearly all operating assets to Nuseed Nutritional US Inc. for $5 million, less outstanding loans and assumed liabilities.

• If approved, the company will proceed with liquidation and dissolution, distributing any remaining assets to shareholders.

• The Board unanimously recommends voting in favor of all proposals, citing a lack of viable alternatives and the best interests of shareholders.

Voting matters and shareholder proposals

• Proposal 1: Approve the sale of substantially all assets to Nuseed.

• Proposal 2: Approve liquidation and dissolution following the asset sale.

• Proposal 3: Grant authority to adjourn the meeting if more time is needed to solicit votes.

• Proposal 4: Amend the certificate of incorporation to reduce authorized common shares from 150,000,000 to 2,000,000, lowering franchise tax liability.

• Board recommends voting FOR all proposals; majority of outstanding shares required for Proposals 1 and 2, majority of votes cast for Proposals 3 and 4.

Board of directors and corporate governance

• Board and management conducted extensive strategic review, including outreach to potential partners and investors over 14 months.

• Board held frequent meetings to evaluate alternatives, ultimately determining the asset sale and dissolution as the only viable path.

• Board retains authority to abandon or delay dissolution if circumstances change before filing the Certificate of Dissolution.